ArticleStem cells translational medicine2021

Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application.

Brian O'Rourke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.